نتائج البحث

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

• Source: Phase IIA Trial of Acolbifene (20 mg) vs Low Dose Tamoxifen (5 mg) in Pre-menopausal Women at High Risk for Development of Breast Cancer

تفاصيل العنوان

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

• Source: Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction (RENAISSANCE): A Phase II Single Arm Trial

تفاصيل العنوان

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (SOFT)

• Authors : Breast International Group; Cancer and Leukemia Group B; National Cancer Institute (NCI)

• Source: A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal

تفاصيل العنوان

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (TEXT)

• Authors : National Cancer Institute (NCI); Breast International Group

• Source: A Phase III Trial Evaluating The Role Of Exemestane Plus GnRH Analogue As Adjuvant Therapy For Premenopausal Women With Endocrine

تفاصيل العنوان

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (EMPRESS)

• Source: Preoperative Window of Opportunity Study With Giredestrant (GDC-9545) or Tamoxifen in Premenopausal Women

تفاصيل العنوان

External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia

• Authors : Chang Gong, Clinical Professor

• Source: External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia: a Double-blind,

تفاصيل العنوان

Effects of adjuvant tamoxifen over three decades on breast cancerefree and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial

• Authors : Ekholm, Maria; Bendahl, P. O.; Ferno, M.

Subjects: Adjuvant therapy; Tamoxifen; Premenopausal

• Source: European Journal of Cancer. 110:53-61

تفاصيل العنوان

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (MONALEESA-7)

• Source: A Phase III Randomized, Double-blind, Placebo-controlled Study of LEE011 or Placebo in Combination With Tamoxifen and Goserelin or a Non-steroidal Aromatase Inhibitor

تفاصيل العنوان

Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study.

• Authors : Yamazaki R; Department of Obstetrics and Gynecology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.; Inokuchi M

Subjects: Premenopause*; Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*adverse effects ; Ovarian Follicle/Ovarian Follicle/Ovarian Follicle/*drug effects

• Source: BMC cancer [BMC Cancer] 2020 Jan 29; Vol. 20 (1), pp. 67. Date of Electronic Publication: 2020 Jan 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy

• Authors : Young Joo Lee; Woo Chul Noh; Sungchan Gwark

Subjects: Breast neoplasms; Chemotherapy; Menstruation

• Source: Breast Cancer Research, Vol 26, Iss 1, Pp 1-9 (2024)

تفاصيل العنوان